RCM
LLY icon

Riverhead Capital Management’s Eli Lilly LLY Stock Holding History

Riverhead Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$8.36M Buy
74,710
+10
+0% +$1.11K 0.31% 70
2019
Q2 		$8.28M Buy
74,700
+4,851
+7% +$571K 0.31% 72
2019
Q1 		$9.06M Buy
69,849
+28,848
+70% +$3.51M 0.37% 50
2018
Q4 		$4.75M Buy
41,001
+9,384
+30% +$1.05M 0.21% 124
2018
Q3 		$3.39M Sell
31,617
-1,114
-3% -$111K 0.12% 224
2018
Q2 		$2.79M Buy
32,731
+2,233
+7% +$183K 0.11% 247
2018
Q1 		$2.36M Sell
30,498
-4,515
-13% -$363K 0.1% 257
2017
Q4 		$2.96M Buy
35,013
+7,103
+25% +$604K 0.13% 208
2017
Q3 		$2.39M Sell
27,910
-2,616
-9% -$215K 0.11% 230
2017
Q2 		$2.51M Sell
30,526
-2,360
-7% -$193K 0.12% 210
2017
Q1 		$2.77M Sell
32,886
-19,350
-37% -$1.55M 0.15% 202
2016
Q4 		$3.84M Sell
52,236
-20,400
-28% -$1.52M 0.24% 121
2016
Q3 		$5.83M Sell
72,636
-17,704
-20% -$1.42M 0.38% 59
2016
Q2 		$5.91M Sell
90,340
-441,522
-83% -$33.2M 0.19% 162
2016
Q1 		$38.3M Buy
531,862
+303,271
+133% +$22.9M 0.54% 34
2015
Q4 		$19.3M Sell
228,591
-441,577
-66% -$36.6M 0.28% 89
2015
Q3 		$56.1M Sell
670,168
-121,631
-15% -$10.3M 0.89% 12
2015
Q2 		$66.1M Buy
791,799
+131,591
+20% +$10M 1% 9
2015
Q1 		$48M Buy
660,208
+317,289
+93% +$22.6M 0.72% 21
2014
Q4 		$23.7M Buy
342,919
+8,081
+2% +$545K 0.36% 79
2014
Q3 		$21.7M Buy
334,838
+22,891
+7% +$1.45M 0.37% 68
2014
Q2 		$19.4M Buy
311,947
+39,708
+15% +$2.37M 0.36% 75
2014
Q1 		$16M Buy
272,239
+35,659
+15% +$1.99M 0.35% 82
2013
Q4 		$12.1M Buy
236,580
+125,580
+113% +$6.29M 0.32% 87
2013
Q3 		$5.58M Buy
111,000
+5,333
+5% +$279K 0.18% 150
2013
Q2 		$5.19M Buy
+105,667
New +$5.75M 0.17% 156

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Riverhead Capital Management's LLY Position: Q3 2019 in Review

Riverhead Capital Management increased its Eli Lilly (LLY) stake by 0.01% in Q3 2019, buying an estimated $1.11K and bringing the position to 74,710 shares worth $8.36M. The position accounts for 0.31% of the portfolio, ranked #70.

Riverhead Capital Management first reported a position in LLY in Q2 2013 and has held it in 26 quarters since. The position peaked at $66.1M in Q2 2015. 1,525 funds tracked by Wall St. Rank hold LLY as of Q3 2019.

  • Riverhead Capital Management held 74,710 shares of Eli Lilly worth $8.36M as of Q3 2019.
  • Riverhead Capital Management bought 10 Eli Lilly shares in Q3 2019, an estimated $1.11K.
  • Eli Lilly made up 0.31% of Riverhead Capital Management's portfolio in Q3 2019, its #70 holding.
  • Riverhead Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's Eli Lilly position peaked at $66.1M in Q2 2015.
  • 1,525 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.